The TradingEdge

[Craig-Ehlo]

$EMMBF / $EMC.V

* Emblem's market cap is minuscule compared to other Canadian LPs (keep in mind they have MJ AND oil license).

* Valuation alone makes Emblem Cannabis a buyout candidate, but new CEO, Nick Dean, is a marketing guru with a long history of acquisitions & mergers.

* Cool / clean branding: https://www.instagram.com/emblemcannabis/

* John Stewart, President of Emblem's Pharmaceutical Division, is the kicker. Previously President and CEO of Purdue Pharma, Mr. Stewart developed and launched OxyContin (among other pharmaceuticals). John Stewart makes this an MJ + biotech play!

* In an effort to conduct proper due diligence, I've been in contact with Emblem's IR department frequently as of late. VERY responsive. I'm beyond impressed.

* Buildout of new facility will commence in Q2 of 2018 with an anticipated completion of Q4 2018. Coincides nicely with rec legalization (much like Aurora Sky).

* Still trading near the 52 week low, while everything else in the sector at or near 52 week highs. Seems like a safe place to park some of my Aurora gains...